Both Strategy and MARA Holdings are overvalued, as suggested by the Value Score of F. In terms of Price/Book, Strategy shares ...

The latest round brings the company's total capital raised to $763 million ahead of its merger with bitcoin-focused Nakamoto ...

Bridge Biotherapeutics (288330), a South Korean biotech company, may be looking to become the country's answer to Strategy ...